Summary

Report Scope
This report analyzes the Middle East and North Africa (MENA) clinical trial markets, using 2023 as a benchmark year, and offers projections for the forecast period from 2024 to 2029, with estimates of compound annual growth rates (CAGR). The report covers many aspects of the market, including clinical advances, economic factors and business considerations, and outlines the market forces impacting the industry and its phases, study types and therapeutic areas. The report segments the clinical trial market into services, solutions and supplies, and examines the regional dynamics influencing the market.
This report excluded Turkey and Israel from its scope because their clinical trial markets are significantly more advanced than other countries in the MENA region. Including these markets would have skewed the analysis and not accurately reflected the opportunities and challenges the rest of the region faces. This approach ensures a focused examination of MENA’s emerging clinical trial landscape, which may be more relevant for companies seeking to expand into less mature markets.
Report Includes
- Analysis of the Middle East and Northern Africa’s (MENA) regional markets for clinical trial infrastructure
- Analyses of the market trends, with revenue data for 2023, estimates for 2024, and projected CAGRs through 2029
- Estimate of the current market size and revenue prospects, accompanied by a market share analysis by sponsor type, clinical trial phase, service type, study type, therapeutic area, and country
- An understanding of the opportunities and progressions in clinical trial studies by some select countries in emerging MENA markets
- Facts and figures pertaining to the current market dynamics, advancements in technology, regulations and prospects
- Insights of the ripple effects of the Ukraine-Russia war on clinical trial operations, including supply chain disruptions, regulatory challenges, and patient recruitment and retention
- Analysis of the industry structure, including stakeholders’ market shares, clinical trial product/services mapping, and recent key developments

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Reasons for Doing this Study
Market Summary
Chapter 2 MENA Clinical Trial Industry Outlook
Global Clinical Trial Market Overview
MENA Share
Evolving MENA Clinical Trial Industry
Infrastructure and Resources: Bridging Gaps in Emerging Markets
Patient Recruitment Potential: Diverse Populations and High Recruitment Rates
Cost-Effectiveness
Regulatory Environment: Harmonization and Local Adaptations
Government Support and Investments
Impact of Regional Policies: Incentivizing Clinical Research
Collaborations Expand Regional Networks
Emerging Trends: Focus on Precision Medicine and Rare Diseases
Growing Demand in Oncology and Rare Diseases
Technological Advances: Digitalizing Clinical Operations
Understanding the MENA Clinical Trial Landscape
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Regulatory Frameworks Driving Trial Feasibility
Growing Patient Population Enhancing Recruitment and Diversity
Technological Advances Streamlining Operations
Collaborations
Personalized Medicine Shaping Trial Design
Market Challenges
Complex Regulatory Landscape
Limited Patient Recruitment and Retention
Insufficient Infrastructure and Site Capacity
Limited Adoption of Digital Technologies
Competition for Key Therapeutic Areas
Market Opportunities
Regulatory Reforms Enabling Faster Approvals
Emerging Focus on Oncology and Rare Diseases
Public-Private Partnerships Boosting Research Capacity
Focus on Precision Medicine and Genomics
Chapter 4 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis, by Sponsor Type
Market Analysis, by Phase
Market Analysis, by Service Type
Market Analysis, by Study Type
Market Analysis, by Therapeutic Area
Chapter 5 Emerging Markets
Egypt
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations
Kingdom of Saudi Arabia (KSA)
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations
Lebanon
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations
United Arab Emirates
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations
Iran
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations
Chapter 6 Russia-Ukraine War Impact Analysis
Overview
Supply Chain Disruptions
Regulatory Challenges
Patient Recruitment and Retention
Geopolitical Risks
Chapter 7 Competitive Landscape
Overview
Competitive Landscape
International CROs and Pharmaceutical Companies
Local CROs and Institutions
Academic and Research Institutions
Mapping of Clinical Trial Product Services
Recent Developments in Clinical Trials in the MENA Region
Concluding Remarks from BCC
Chapter 8 Appendix
Methodology
Research Steps
Sources
Abbreviations